S

Shanghai Wanye Enterprises Co Ltd
SSE:600641

Watchlist Manager
Shanghai Wanye Enterprises Co Ltd
SSE:600641
Watchlist
Price: 18.95 CNY 5.81% Market Closed
Market Cap: ¥17.3B

Net Margin

11.8%
Current
Declining
by 4.8%
vs 3-y average of 16.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
11.8%
=
Net Income
¥157.9m
/
Revenue
¥1.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
11.8%
=
Net Income
¥157.9m
/
Revenue
¥1.3B

Market Distribution

Higher than 76% of companies in China
Percentile
76th
Based on 8 721 companies
76th percentile
11.8%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Shanghai Wanye Enterprises Co Ltd
Glance View

Market Cap
17.3B CNY
Industry
Real Estate

Shanghai Wanye Enterprises Co Ltd has traversed an intriguing journey from its origins, evolving into a dynamic player in several sectors. Rooted in the bustling metropolis of Shanghai, the company navigates multiple industries with a focus on real estate, biotechnology, and high-tech investments. Over the years, Wanye has astutely recognized the potential in blending traditional real estate ventures with new-age biotech innovations. Its real estate arm concentrates primarily on the development and management of commercial and residential properties, leveraging its deep understanding of urban landscapes to maximize asset value. Meanwhile, its interest in biotechnology represents a strategic pivot towards high-growth sectors, signifying an alignment with global trends in health and science innovations. Money-making for Wanye Enterprises involves a sophisticated balance of developing high-demand real estate projects and acquiring stakes in promising biotech start-ups and technological ventures. This dual approach not only diversifies its revenue streams but also mitigates risks associated with market fluctuations in single sectors. The company's real estate segment generates consistent cash flow through property sales and rental income, underwriting its forays into the less predictable biotech sector. Meanwhile, investments in technology and biotechnology hold the potential for substantial returns, underpinning growth through innovations that could revolutionize industries. Through strategic investment, development expertise, and market adaptability, Shanghai Wanye Enterprises Co Ltd effectively harnesses various economic waves, positioning itself as a resilient business entity in China's rapidly evolving economic landscape.

Intrinsic Value
5.73 CNY
Overvaluation 70%
Intrinsic Value
Price
S
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
11.8%
=
Net Income
¥157.9m
/
Revenue
¥1.3B
What is Shanghai Wanye Enterprises Co Ltd's current Net Margin?

The current Net Margin for Shanghai Wanye Enterprises Co Ltd is 11.8%, which is below its 3-year median of 16.6%.

How has Net Margin changed over time?

Over the last 3 years, Shanghai Wanye Enterprises Co Ltd’s Net Margin has decreased from 25.5% to 11.8%. During this period, it reached a low of -8.6% on Sep 30, 2024 and a high of 40.2% on Mar 31, 2023.

Back to Top